Neu: Nutzen Sie neue Funktionen auf finanzen.net als Erstes - hier informieren!
26.05.2022 19:30

Global Sevoflurane Market to Surpass US$ 522.8 Million by 2030 - Coherent Market Insights

Folgen
Werbung

SEATTLE, May 26, 2022 /PRNewswire/ -- According to Coherent Market Insights' analysis, the global sevoflurane market is estimated to be valued at US$ 370.2 Million in 2022 and is expected to exhibit a CAGR of  4.4% during the forecast period (2022-2030).

Coherent_Market_Insights_Logo

Key Trends and Analysis of the Global Sevoflurane Market:

Key trends in the market include increasing launch of ambulatory surgery centers, and increasing research and development activities.

Market players focused on launch of ambulatory surgery centers and their business is expected to drive the market growth of global sevoflurane market over the forecast period. For instance, on July 6, 2020, Stryker Corporation, an American multinational medical technology corporation, launched an ambulatory surgery center (ASC). Stryker's aim is to offer thousands of unique products spanning more than 20 procedural specialties.

Market players are involved in research and development activities related to sevoflurane, which is expected to drive the growth of the global sevoflurane market. For instance, in April 2021, University of Malaya, a public research university located in Kuala Lumpur, Malaysia, initiated a Phase 4 study for comparing sevoflurane with propofol sedation in end-stage renal failure (ESRF) patients for transposition of brachiocephalic fistula repair.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/5031

Key Market Takeaways:

Increasing research and development activities, rising product launches and approvals, inorganic activities such as collaborations, agreements, acquisitions, and others are expected to drive growth of the global sevoflurane market over the forecast period. For instance, in November 2021, Tenet Healthcare Corporation, a diversified healthcare services organization and its subsidiary United Surgical Partners International (USPI), announced that they had reached a definitive agreement with the principals of SurgCenter Development (SCD) to acquire SCD. Tenet/USPI will acquire SCD's ownership interests in 92 ambulatory surgery centers (ASCs) and related ambulatory support services under the terms of the deal.

Key players operating in the global sevoflurane market include Abbott Laboratories, Baxter, Piramal Pharma Solutions, Manus Aktteva Biopharma LLP, Maruishi Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group, Abbvie, Wellona Pharma, Rewine Pharmaceutical, and Troikaa Pharmaceuticals Limited.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/5031

Detailed Segmentation:

Global Sevoflurane Market, By Application:

  • Induction
  • Maintenance

Global Sevoflurane Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Sevoflurane Market, By Region:

  • North America
    • By Country:
      • U.S.
      • Canada
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • By Country:
      • GCC Countries
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/5031

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com 
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedInTwitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg  

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Ukraine-Krieg im Ticker: DAX geht etwas fester ins Wochenende -- US-Börsen schließen stark-- Siemens nimmt Milliarden-Abschreibung auf Siemens Energy vor -- Commerzbank, TUI, JENOPTIK, BMW im Fokus

BMW: Empfindlicher Dämpfer bei US-Verkäufen. USA bestellt erneut Affenpocken-Impfstoff bei Bavarian Nordic. Porsche setzt in den USA im zweiten Quartal mehr Autos ab. Salmonellen-Schokolade von Barry Callebaut ist nicht in Läden gelangt. BASF und MAN wollen gemeinsam riesige Wärmepumpe in Ludwigshafen bauen.

Die 5 beliebtesten Top-Rankings

mehr Top Rankings

Umfrage

Goldpreis im Fokus der Anleger: Sind Sie in Gold investiert?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln